Safety, Tolerability and Pharmacokinetic of Multiple-ascending Doses of LPM3770164 in Healthy Subjects
Clinical trial NCT06216054 · COMPLETED
Trial details
- NCT number
- NCT06216054
- Sponsor
- Luye Pharma Group Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-19
- Primary completion
- 2024-07-29
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.